Article
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.
Genes & development - 15 Jun 2012
Liu-Chittenden Yi, Huang Bo, Shim Joong Sup, Chen Qian, Lee Se-Jin, Anders Robert A, Liu Jun O, Pan Duojia
Abstract excerpt
The Drosophila TEAD ortholog Scalloped is required for Yki-mediated overgrowth but is largely dispensable for normal tissue growth, suggesting that its mammalian counterpart may be exploited for selective inhibition of oncogenic growth driven by YAP hyperactivation. Here we test this hypothesis genetically and pharmacologically. We show that a dominant-negative TEAD molecule does not perturb normal liver growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
